Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Beet It Sport Shot
Aspire Biopharma Holdings
Blood Pressure
1 trial -
Belsomra
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
Benazepril
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Renal Insufficiency,Chronic
1 trial -
Benazepril
Sun Yat-sen University
Renal Function Disorder
1 trial -
Benralizumab
Grace Therapeutics
Asthma; Eosinophilic
1 trial -
Best medical management
The First People's Hospital of Lianyungang
Stroke, Ischemic
1 trial -
Betaine
Ultragenyx UK Limited
Angelman Syndrome
1 trial -
Bevacizumab
The First People's Hospital of Lianyungang
Brain Glioma
1 trial -
Beverage powder fortified with micronutrients and Bacopa monnieri extract
COGNITION THERAPEUTICS INC
Cognition
1 trial -
Bifidobacterium
The First People's Hospital of Lianyungang
Depressive Disorder
1 trial -
BioAmicus Complete
Hong Kong Baptist University
Infantile Colic
1 trial -
Biobanking with genetic analysis
Chongqing Precision Biotech Co., Ltd
Chronic Inflammatory Disease
1 trial -
Biobran supplementation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer Stages I
1 trial -
Biolizin
Hong Kong Baptist University
Feeding and Eating Disorders of Childhood
1 trial -
Bivalirudin
The First People's Hospital of Lianyungang
ST-segment Elevation Myocardial Infarction (STEMI)
1 trial -
Blinatumomab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Adult ALL
1 trial -
Blinatumomab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
B-ALL
1 trial -
Blood draw for Lp(a)
Novartis Pharmaceuticals
Cardiovascular Disease and Lipoprotein(a)
1 trial -
Blood ponction
MAIA Biotechnology
Alzheimer Blood Biomarkers
1 trial -
Blood sample
Ultragenyx UK Limited
Amelogenesis Imperfecta
1 trial -
Blueberries
United Therapeutics Europe Ltd
Healthy Adults
1 trial -
Blueberry, cranberry, green tea extract, cocoa
United Therapeutics Europe Ltd
Stress, Psychological
1 trial -
Boost to the tumour bed
United Therapeutics Europe Ltd
Early Breast Cancer
1 trial -
Bottle pack
Summit Therapeutics
Pregnancy
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources